Omics-Based Clinical Trials Market size is anticipated to reach USD 49.5 billion by 2030
Omics-Based Clinical Trials Industry Overview The global omics-based clinical trials market size was valued at USD 26.2 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.4% from 2022 to 2030. There was unprecedented growth in 2020 due to the COVID-19 pandemic. The main drivers were rising investment in the pharmaceutical industry by the prominent participants to enhance their productivity, rising demand for omics-based clinical trials, and increasing prevalence of chronic disorders. With the increasing global prevalence and burden of various chronic diseases such as cancer, there is a demand to study various molecular targets that may not only provide biomarkers of clinical risk, but also therapeutic targets. Gather more insights about the market drivers, restrains and growth of the Global Omics-Based Clinical Trials Market Advanced omics technologies such as single-cell omics, multi-omics, and typical om...